| Authors: |
Teleanu MV; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany. Electronic address: maria-veronica.teleanu@nct-heidelberg.de., Heilig CE; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany., Pirmann S; Computational Oncology Group, Molecular Precision Oncology Program, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany., Hamacher R; Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Hospital Essen, Essen, Germany; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany., Bauer S; Department of Medical Oncology and Sarcoma Center, West German Cancer Center, University Hospital Essen, Essen, Germany; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany., Gaidzik VI; Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany., Mayer-Steinacker R; Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany., Al-Sabah J; Computational Oncology Group, Molecular Precision Oncology Program, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany., Roldan Pinzon SSL; NCT Trial Center, DKFZ and Heidelberg University Hospital, Heidelberg, Germany., Süße H; NCT Trial Center, DKFZ and Heidelberg University Hospital, Heidelberg, Germany., Freitag A; NCT Trial Center, DKFZ and Heidelberg University Hospital, Heidelberg, Germany., Horak P; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany., Kreutzfeldt S; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany., Hutter B; Computational Oncology Group, Molecular Precision Oncology Program, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany., Hüllein J; Computational Oncology Group, Molecular Precision Oncology Program, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany., Sedlaczek O; Divison of Radiology, German Cancer Research Center, Heidelberg, Germany., Lehner B; Department of Orthopaedics, Heidelberg University Hospital, Heidelberg, Germany., Egerer G; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Jäger D; Department of Medical Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany., Müller-Tidow C; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany., Hübschmann D; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany; Computational Oncology Group, Molecular Precision Oncology Program, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Pattern Recognition and Digital Medicine Group, Heidelberg, Germany; Innovation and Service Unit for Bioinformatics and Precision Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany., von Kalle C; Berlin Institute of Health, Berlin, Germany., Barth TFE; Institute of Pathology, Ulm University Hospital, Ulm, Germany., Fröhling S; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany., Schlenk RF; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany; NCT Trial Center, DKFZ and Heidelberg University Hospital, Heidelberg, Germany; Department of Medical Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany. |
